Publication

EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in Non-Small Cell Lung Cancer

Journal Paper/Review - Jun 14, 2019

Units
PubMed
Doi

Citation
Früh M, Peters S. EGFR mutation subtype impacts efficacy of immune checkpoint inhibitors in Non-Small Cell Lung Cancer. Ann Oncol 2019
Type
Journal Paper/Review (English)
Journal
Ann Oncol 2019
Publication Date
Jun 14, 2019
Issn Electronic
1569-8041
Brief description/objective